Table 1 Clinical applications of partial ROS-related ncRNAs in cancer patients
From: The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role
NcRNA | Type | Cancer | Application | Status | Identifier |
|---|---|---|---|---|---|
MiR-373 | NA | Breast cancer | Cancer diagnosis | Recruiting | NCT04720508 |
MiR-155 | NA | Bladder cancer | Cancer diagnosis | Completed | NCT03591367 |
MiR-371 | NA | Germ cell cancer | Cancer diagnosis | Recruiting | NCT04435756 |
HOTAIR | NA | Thyroid cancer | Cancer diagnosis | Unknown | NCT03469544 |
MiR-16 | Mimic | Pleural mesothelioma lung cancer | Cancer therapy | Phase I | NCT02369198 |
MiR-122 | ASO | Liver cancer | Cancer therapy | Phase I/II | NCT01646489, NCT01727934, NCT01872936, NCT01200420 |
MiR-155 | ASO | T-cell lymphoma | Cancer therapy | Phase II | NCT03713320, NCT03713320 |
MiR-34a | Mimic | Melanoma | Cancer therapy | Phase I | NCT01829971, NCT02862145 |
MtlncRNA | ASO | Unresectable tumors | Cancer therapy | Phase I | NCT02508441, NCT03985072 |